High-performance liquid chromatographic determination of flavoxate hydrochloride and its hydrolysis product

Drug Development and Industrial Pharmacy

Volumn 34, Issue 12, 2008, Pages 1311-1322

  El Gindy, Alaa ^a   Abdel Salam, Randa A ^a   Sallam, Shehab ^b  

^a Suez Canal University   (Egypt)

^b Suez Canal University   (Egypt)

Author keywords

Arrhenius plot; Flavoxate hydrochloride; HPLC; Kinetics of hydrolysis; pH rate profile

Indexed keywords

3 METHYLFLAVONE 8 CARBOXYLIC ACID ETHYL ESTER; ACETONITRILE; AMMONIUM ACETATE; CARBOXYLIC ACID DERIVATIVE; FLAVONE DERIVATIVE; FLAVOXATE; UNCLASSIFIED DRUG;

ACIDITY; ANALYTIC METHOD; ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG HYDROLYSIS; DRUG IMPURITY; ENERGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLAVOXATE; HYDROGEN-ION CONCENTRATION; HYDROLYSIS;

EID: 57349124519     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802071984     Document Type: Article

References (15)

1. Bertoli, M., Conti, F., Conti, M., Cova, A., & Setnikar, I. (1976). Pharmacokinetics of flavoxate in man. Pharmacol. Res. Comm., 8, 417-428.
2. Brezina, M., & Zuman, P. (1958). Polarography in medicine, biochemistry, and pharmacy, interscience, Interscience Publ., New York.
3. British Pharmacopoeia. (2005). Specific monographs (p. 731). London: Stationery Office.
4. Cazzulani, P., Pietra, C., Abbiati, G. A., Ceserani, R., Oliva, D., Civelli, M., Tajana, A., & Nardi, D. (1988). Pharmacological activities of the main metabolite of flavoxate 3-methylflavone-8-carboxylic acid. Arzneimittelforschung, 38, 379-382.
5. Cazzulani, P., Panzarasa, R. C., Luca, C., Oliva, D., & Graziani, G. (1984). Pharmacological studies on the mode of action of flavoxate. Arch. Int. Pharmacodyn. Ther., 268, 301-312.
6. Cova, A., & Setnikar, I. (1975). Pharmacokinetics of flavoxate in rats. Arzneimittelforschung, 25, 1707-17012.
7. El-Gindy, A., Sallam, S., & Abdel-Salam, R. A. (2007). High performance liquid chromatographic determination of 3-methylflavone-8-carboxylic acid, the main active metabolite of flavoxate hydrochloride in human urine. J. Chromatogr. B. Biomed. Appl., 44, 274-278.
8. Pedersen, E. (1977). Studies on the effect and mode of action of flavoxate in human urinary bladder and sphincter. Urol. Int., 32, 202-208.
9. Sheu, M. T., Yeh, G. C., Ke, W. T., & Ho, H. O. (2001). Development of a high-performance liquid chromatographic method for bioequivalance study of flavoxate tablets. J. Chromatogr. B. Biomed. Appl., 751, 79-86.
10. Sweetman, S. C. (2002). Martindale: The complete drug reference (33rd ed.). Pharmaceutical Press. (Electronic Version).
11. The European Agency for the Evaluation of Medical Products. (1996). ICH Topic Q2B note for Guidance on validation of analytical procedures: Methodology (No. GPMP/ICH/281/95) (pp.1-8). Geneva, Switzerland: IFPMA.
12. Wang, Y., Wang, T. J., & Zhang, T. L. (2002). RP-IP-HPLC Determination of Flavoxate Hydrochloride Tablets. J. Yaowu Fenxi Zazhi, 22, 202-205.
13. Zarapkar, S. S., Salunkhe, U. B., Salunkhe, B. B., Doshi, V. J., Sawant S. V., & Rele, R. V. (1989). High-performance liquid-chromatographic determination of flavoxate hydorchloride from pharmaceutical preparations. Indian Drugs, 26(3), 354-356.
14. Zhang, C. X., Sun, Z. P., Ling, D. K., Zheng, J. S., Guo, J., & Li, X. Y. (1993). Determination of 3-methylflavone-8-carboxylic acid, the main metabolite of flavoxate, in human urine by capillary electrophoresis with direct-injection. J. Chromatogr. B. Biomed. Appl., 123, 287-294.
15. Zheng, Y. (1993). Ultra-violet spectrophotometric determination of flavoxate hydrochloride tablets. J. Yaowu Fenxi Zazhi, 13, 339-340.